<?xml version="1.0" encoding="UTF-8"?>
<p id="p0060">The present study reviews the efficacy of many dietary flavonols as potential antiviral drugs targeting the SARS-CoV-2 enzymes. Papers recently published (from January to August 2020) in PubMed, Google Scholar, and Science Direct databases were selected for data extraction. Firstly, All articles evaluating the effects of flavonoids on COVID-19 infection, written in English language and containing the following keywords: COVID-19, viral infection, flavonoids, flavonols, docking, 
 <italic>in silico</italic>, M
 <sup>pro</sup>, 3CL
 <sup>pro</sup>, PL
 <sup>pro</sup>, RdRp, S protein, and ACE2 receptor were researched and selected regardless of publication types. Then, the results of the initial search were filtered by the lecture of their title and abstract. Studies with insufficient or duplicated information were excluded from the review. After the first selection, the full texts of the selected papers were read and only eligible and pertinent articles containing information about flavonols were included and chosen for data extraction. All the selected flavonols in the chosen data were cited in the library of natural products based on adherence to Lipinski's rule of five and Veber's Rule, and also for their antiviral, anti-inflammatory, immunomodulatory, and protective effects.
</p>
